Marico Q1 FY27: Board meeting Aug 4, copra drop lifts profit

What investors are tracking this week

Marico has scheduled a board meeting on August 04, 2026 to consider and approve the audited financial results for the quarter ended June 30, 2026. The quarter corresponds to Q1 FY 2026-2027 (Q1 FY27). The announcement comes after the company issued an operating performance update outlining demand trends for the June quarter. That update pointed to broad-based growth across its core, digital, and international businesses. It also flagged a likely sequential improvement in gross margin because of a correction in copra prices. For investors, the August 4 board meeting is the next formal milestone, since the company indicated a detailed information update would follow once results are approved.

Board meeting details: August 04, 2026

The company has stated that its board meeting is scheduled for August 04, 2026. The stated agenda is to consider and approve the audited financial results for the quarter ended June 30, 2026. In its communication on the quarter, Marico also said the operating update is a summary of performance and demand trends, and a detailed information update will follow after board approval of the financial results. The timing matters because the operating update contains directional commentary on revenue, margins, and category performance, but not the complete financial statements. The board meeting is therefore expected to be the point at which the company releases the quarter’s formal numbers.

Q1 FY27 operating update: revenue growth seen in “early twenties”

For Q1 FY27, Marico said it expects consolidated revenue to grow in the “early twenties” year-on-year. The company attributed the expected growth to strong performance across its core, digital, and international businesses. It also reported that the India business showed accelerated momentum with double-digit underlying volume growth, described as the highest in several quarters. Within the portfolio, Parachute Coconut Oil delivered double-digit volume growth, the first time it reached that level in several quarters as per the update. Saffola Oils saw mid-single digit price-led revenue growth, while volumes declined due to supply rationalization. Value Added Hair Oils delivered revenue growth in the twenties, supported by a focus on mid and premium segments and expanded direct reach through Project SETU.

International business trends flagged in the June-quarter update

Marico’s operating update said its international business posted mid-teens constant currency growth in Q1 FY27. The growth was described as being led by Vietnam and the Middle East and North Africa (MENA) region. This is relevant for understanding the breadth of demand, as the company’s earlier Q1 FY26 disclosures also highlighted meaningful international contribution, although the regional mix differed then. The company has not provided country-level numbers in the Q1 FY27 operating update excerpt provided here, but it has positioned international performance as one of the key drivers behind the consolidated growth expectation.

Copra prices and margins: why the company expects profit growth

Marico expects gross margin to improve sequentially in Q1 FY27 due to a significant correction in copra prices. It also said investments in brand building accelerated during the quarter. Even with higher brand investments, the company said it anticipates strong operating profit growth, driven by robust business growth and the softening in copra prices. A key data point highlighted alongside these expectations is a 45% decline in copra prices from their peak levels. Since copra is a major input for coconut oil, the correction is important for the cost structure of categories linked to coconut-based products.

How the market reacted: 52-week high and intraday move

Marico’s stock reaction was sharp around the operating update. Shares rose 2% to hit a 52-week high of ₹873 on Friday, July 3, following the company’s statement that consolidated revenue for the quarter ended June 30, 2026 was expected to grow in the early twenties. Later, at 10:20 AM, Marico shares were seen at ₹841.15 on the National Stock Exchange, down 1.73%. The stock touched an intraday low of ₹839.20 per share after hitting the 52-week high level. These moves show that the market responded quickly to the growth commentary, and then saw volatility around the peak levels.

What Q1 FY26 showed: a reference point for operating momentum

Marico’s Q1 FY26 (quarter ended June 30, 2025) disclosures provide a useful reference for how growth and margins can diverge when input costs rise. The company reported 9% year-on-year volume growth in India and 23% consolidated revenue growth in Q1 FY26, supported by pricing actions and strength in premium and digital segments. Q1 FY26 consolidated revenue from operations rose 23% year-on-year to ₹3,259 crore, with India business revenues up 27% and international revenues up 12% in INR terms. EBITDA increased 5% year-on-year to ₹655 crore, while EBITDA margin stood at 20.1%, down 360 basis points year-on-year. Reported PAT grew 9% year-on-year to ₹504 crore, while consolidated net profit for the quarter was ₹480 crore. Consolidated basic EPS was ₹3.90, up from ₹2.65 year-on-year.

Snapshot table: key financial metrics disclosed for Q1 FY26

All figures are in ₹ crore, except EPS.

Corporate actions and past board approvals

In Q1 FY26, the board approved unaudited standalone and consolidated results for the quarter ended June 30, 2025, after review by statutory auditors and the Audit Committee. Marico also disclosed the acquisition of an additional 8.8% stake in Satiya Nutraceuticals Private Limited (Plix), taking its total holding to 60%. These disclosures underline that Marico has used quarterly board meetings not only for results approval but also to communicate capital allocation decisions. For FY 2025-26, Marico recorded a turnover of ₹13,610 crore (converted from ₹136.1 billion) through products sold in India and selected markets globally.

What to watch after the August 04 board meeting

Marico has already said a detailed information update will follow once the board approves the financial results for Q1 FY27. Investors will look to reconcile the “early twenties” revenue growth expectation with the final reported number, and assess the extent of sequential gross margin improvement linked to copra’s correction. Attention will also remain on category-level commentary, particularly in Parachute Coconut Oil and Value Added Hair Oils, and on how Saffola Oils volumes track after supply rationalization. The board meeting on August 04, 2026 is the clear next event on the calendar for these confirmations.